Klaviyo Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
KVYO$20.43-1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Balance Sheets
Consolidated Balance Sheets
| As of, | ||
|---|---|---|
| December 31, 2023 | December 31, 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $738,562 | $385,820 |
| Restricted cash | 409 | 409 |
| Accounts receivable, net of allowance for doubtful accounts | 23,076 | 10,723 |
| Deferred contract acquisition costs, current | 15,198 | 11,215 |
| Prepaid expenses and other current assets | 26,244 | 19,336 |
| Total current assets | 803,489 | 427,503 |
| Property and equipment, net | 43,450 | 45,837 |
| Right-of-use assets, net | 36,987 | 45,695 |
| Deferred contract acquisition costs, non-current | 23,177 | 15,983 |
| Restricted cash, non-current | 686 | 687 |
| Prepaid marketing expense | 173,844 | 84,415 |
| Other non-current assets | 7,417 | 8,959 |
| Total assets | $1,089,050 | $629,079 |
| Liabilities, Redeemable Common Stock, and Stockholders’ Equity (Deficit) | ||
| Current liabilities: | ||
| Accounts payable | $13,597 | $8,890 |
| Accrued expenses | 62,838 | 36,126 |
| Lease liabilities, current | 14,081 | 14,864 |
| Deferred revenue | 40,100 | 25,109 |
| Total current liabilities | 130,616 | 84,989 |
| Lease liabilities, non-current | 37,498 | 47,544 |
| Other non-current liabilities | 6,159 | 876 |
| Total liabilities | 174,273 | 133,409 |
| Redeemable Common Stock (Note 11) | ||
| Redeemable common stock, $0.001 par value, 0 and 64,046,223 shares issued and outstanding at December 31, 2023 and 2022, respectively. | $— | $1,531,853 |
| Stockholders’ Equity (Deficit) | ||
| Preferred stock: $0.001 par value; 100,000,000 and 0 shares authorized; 0 and 0 shares issued; 0 and 0 shares outstanding at December 31, 2023 and 2022, respectively. | — | — |
| Series A common stock: $0.001 par value; 3,000,000,000 and 0 shares authorized; 40,841,834 and 0 shares issued; 40,841,834 and 0 shares outstanding at December 31, 2023 and 2022, respectively. | 41 | — |
| Series B common stock: $0.001 par value; 350,000,000 and 316,000,000 shares authorized; 218,524,009 and 170,882,108 shares issued; 218,524,009 and 170,855,313 shares outstanding at December 31, 2023 and 2022, respectively. | 219 | 171 |
| Additional paid-in capital | 1,713,560 | 1,249,065 |
| Accumulated deficit | (799,043) | (2,285,419) |
| Total stockholders’ equity (deficit) | 914,777 | (1,036,183) |
| Total liabilities, redeemable common stock, and stockholders’ equity (deficit) | $1,089,050 | $629,079 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.